Abstract
Background
A limited number of studies have evaluated the risk of developing venous thromboembolism (VTE) during neoadjuvant chemotherapy (NAC) for esophageal cancer and the efficacy of a D-dimer (DD)-based VTE screening (DBS). In the present study, we aimed to clarify the changes in DD levels and the effectiveness of DBS.
Methods
We included 234 patients who underwent esophagectomy between August 2017 and July 2019 and evaluated the changes in DD levels before and after NAC. We had introduced the DBS strategy in August 2018, in which we recommended ultrasound (US) of the leg or computed tomography (CT) with the deep vein thrombosis (DVT) protocol. We then evaluated the incidence of VTE detected by DBS compared with that in the clinical practice as a control.
Results
The DD levels were significantly increased after NAC. After the introduction of DBS, the proportion of patients who underwent US and CT after NAC was significantly increased. VTE was more frequently detected in the DBS group than in the control group (16.7% vs. 3.0%, p < 0.02) among patients who underwent NAC. Pulmonary embolism (PE) during NAC was also more frequent in the DBS than in the control group (7.6% vs. 1.5%, p = 0.06). The DD levels after NAC were significantly higher in patients with VTE than in those without.
Conclusions
NAC for patients with esophageal cancer increases the risk of developing VTE. DBS is useful in identifying asymptomatic DVT and may contribute to improving patient safety.
Similar content being viewed by others
References
Byrne M, Reynolds JV, O’Donnell JS et al (2010) Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer 102(1):73–79. https://doi.org/10.1038/sj.bjc.6605463
Heit JA, Silverstein MD, Mohr DN et al (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160(6):809–815
Agnelli G, Bolis G, Capussotti L et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89–95. https://doi.org/10.1097/01.sla.0000193959.44677.48
Lordick F, Mariette C, Haustermans K et al (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol: Off J Eur Soc Med Oncol 27(suppl 5):v50–v57. https://doi.org/10.1093/annonc/mdw329
Ajani JA, D’Amico TA, Bentrem DJ et al (2019) Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compre Cancer Netw: JNCCN 17(7):855–883. https://doi.org/10.6004/jnccn.2019.0033
Kuwano H, Nishimura Y, Oyama T et al (2015) Guidelines for diagnosis and treatment of carcinoma of the esophagus april 2012 edited by the japan esophageal society. Esophagus 12:1–30. https://doi.org/10.1007/s10388-014-0465-1
Bosch DJ, Van Dalfsen QA, Mul VE et al (2014) Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. Am J Surg 208(2):215–221. https://doi.org/10.1016/j.amjsurg.2013.10.031
Khanna A, Reece-Smith AM, Cunnell M et al (2014) Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer. Dis Esophagus 27(3):242–247. https://doi.org/10.1111/dote.12084
Parakh RS, Sabath DE (2019) Venous thromboembolism: role of the clinical laboratory in diagnosis and management. J Appl Lab Med 3(5):870–882. https://doi.org/10.1373/jalm.2017.025734
Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878–2887. https://doi.org/10.1182/blood-2008-06-165845
Thachil J, Lippi G, Favaloro EJ (2017) D-dimer testing: laboratory aspects and current issues. Methods Mol Boil (Clifton, NJ) 1646:91–104. https://doi.org/10.1007/978-1-4939-7196-1_7
Bates SM, Jaeschke R, Stevens SM et al (2012) Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e351S-e418S. https://doi.org/10.1378/chest.11-2299
Sobin LH, Compton CC (2010) TNM seventh edition: what’s new, what’s changed: communication from the international union against cancer and the American joint committee on cancer. Cancer 116(22):5336–5339. https://doi.org/10.1002/cncr.25537
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244
Kimura Y, Oki E, Ando K et al (2016) Incidence of venous thromboembolism following laparoscopic surgery for gastrointestinal cancer: a single-center, prospective cohort study. World J Surg 40(2):309–314. https://doi.org/10.1007/s00268-015-3234-y
Rollins KE, Peters CJ, Safranek PM et al (2011) Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery. Eur J Surg Oncol: J Eur Soc Surg Oncol British Assoc Surg Oncol 37(12):1072–1077. https://doi.org/10.1016/j.ejso.2011.08.140
Marshall-Webb M, Bright T, Price T et al (2017) Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy. Dis Esophagus 30(2):1–7. https://doi.org/10.1111/dote.12516
Seng S, Liu Z, Chiu SK et al (2012) Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol: Off J Am Soc Clin Oncol 30(35):4416–4426. https://doi.org/10.1200/jco.2012.42.4358
Kato F, Takeuchi H, Matsuda S et al (2016) Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surg Today 46(4):445–452. https://doi.org/10.1007/s00595-015-1196-1
Chopra V, Anand S, Hickner A et al (2013) Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet (London, England) 382(9889):311–325. https://doi.org/10.1016/s0140-6736(13)60592-9
Jasti N, Streiff MB (2014) Prevention and treatment of thrombosis associated with central venous catheters in cancer patients. Expert Rev Hematol 7(5):599–616. https://doi.org/10.1586/17474086.2014.954541
Tetzlaff ED, Correa AM, Komaki R et al (2008) Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction. Dis Esophagus 21(7):575–581. https://doi.org/10.1111/j.1442-2050.2008.00829.x
Larsen AC, Frokjaer JB, Fisker RV et al (2015) Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer—a clinical prospective study of outcome and prognostic factors. Thromb Res 135(5):802–808. https://doi.org/10.1016/j.thromres.2015.01.021
Schieman C, Wigle DA, Deschamps C et al (2012) Patterns of operative mortality following esophagectomy. Dis Esophagus 25(7):645–651. https://doi.org/10.1111/j.1442-2050.2011.01304.x
Hata T, Ikeda M, Miyata H et al (2019) Frequency and risk factors for venous thromboembolism after gastroenterological surgery based on the Japanese national clinical database (516 217 cases). Ann Gastroenterol Surg 3(5):534–543. https://doi.org/10.1002/ags3.12275
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No author has any conflict of interest
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Takahashi, K., Watanabe, M., Kanie, Y. et al. Significance of D-dimer-based screening for detecting pre-operative venous thromboembolism in patients with esophageal cancer after neoadjuvant chemotherapy. Int J Clin Oncol 26, 1083–1090 (2021). https://doi.org/10.1007/s10147-021-01886-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-021-01886-z